Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Andes

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|September 12, 2012
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia modelAlexander J Lepak, Karen Marchillo, Solen Pichereau, et al.
Organic Letters|September 19, 2012
Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylationPauline Peltier-Pain, Karen Marchillo, Maoquan Zhou, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2017
Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing DesignAlexander J Lepak, Miao Zhao, Brian VanScoy, et al.
Pharmaceutical Research|February 17, 2017
Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium SupplementationCeleste Alvarez, David R Andes, Jeong Yeon Kang, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
Identification of the <i>In Vivo</i> Pharmacokinetics and Pharmacodynamic Driver of IclaprimJee Hyun Park, William Craig, Karen Marchillo, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2024
<i>In vivo</i> pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse modelAlexander J Lepak, Brian VanScoy, Chris Rubino, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
Reduced biocide susceptibility in Candida albicans biofilmsJeniel E Nett, Kristie M Guite, Alex Ringeisen, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2016
Targeting Fibronectin To Disrupt In Vivo Candida albicans BiofilmsJeniel E Nett, Jonathan Cabezas-Olcoz, Karen Marchillo, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Pharmacodynamic Optimization for Treatment of Invasive Candida auris InfectionAlexander J Lepak, Miao Zhao, Elizabeth L Berkow, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2015
In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection ModelAlexander J Lepak, Ajit Parhi, Michaela Madison, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|September 12, 2012
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia modelAlexander J Lepak, Karen Marchillo, Solen Pichereau, et al.
Organic Letters|September 19, 2012
Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylationPauline Peltier-Pain, Karen Marchillo, Maoquan Zhou, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2017
Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing DesignAlexander J Lepak, Miao Zhao, Brian VanScoy, et al.
Pharmaceutical Research|February 17, 2017
Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium SupplementationCeleste Alvarez, David R Andes, Jeong Yeon Kang, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
Identification of the <i>In Vivo</i> Pharmacokinetics and Pharmacodynamic Driver of IclaprimJee Hyun Park, William Craig, Karen Marchillo, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2024
<i>In vivo</i> pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse modelAlexander J Lepak, Brian VanScoy, Chris Rubino, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
Reduced biocide susceptibility in Candida albicans biofilmsJeniel E Nett, Kristie M Guite, Alex Ringeisen, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2016
Targeting Fibronectin To Disrupt In Vivo Candida albicans BiofilmsJeniel E Nett, Jonathan Cabezas-Olcoz, Karen Marchillo, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Pharmacodynamic Optimization for Treatment of Invasive Candida auris InfectionAlexander J Lepak, Miao Zhao, Elizabeth L Berkow, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2015
In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection ModelAlexander J Lepak, Ajit Parhi, Michaela Madison, et al.
Pageof 21